Hawiger J, Timmons S, Kloczewiak M, Strong D D, Doolittle R F
Proc Natl Acad Sci U S A. 1982 Mar;79(6):2068-71. doi: 10.1073/pnas.79.6.2068.
Fibrinogen, a clottable plasma protein, agglutinates both prokaryotic cells (e.g., staphylococci) and eukaryotic cell fragments (e.g., platelets) through interaction with specific receptors. To identify the region of the fibrinogen molecule responsible for its interaction with human platelets, we prepared polypeptide chain subunits (alpha, beta, and gamma) of human fibrinogen by reduction and carboxymethylation. A mixture of the chains induced aggregation (clumping) of human platelets separated from plasma proteins and treated with ADP. When individual chains of fibrinogen were tested, gamma-chain multimers caused platelet aggregation at a molar concentration comparable with that of intact human fibrinogen. The beta chain remained inactive, and the alpha chain was 1/4th to 1/5th as reactive as the gamma chain. Monospecific antibody fragments against the gamma chain inhibited binding of 125I-labeled fibrinogen to the human platelet receptor and blocked aggregation of platelets induced by ADP in the presence of fibrinogen or gamma-chain multimers. These results indicate that the gamma chain of human fibrinogen bears the main site for interaction with the platelet receptor.
纤维蛋白原是一种可凝结的血浆蛋白,通过与特定受体相互作用,能使原核细胞(如葡萄球菌)和真核细胞碎片(如血小板)发生凝集。为了确定纤维蛋白原分子中负责与人类血小板相互作用的区域,我们通过还原和羧甲基化制备了人纤维蛋白原的多肽链亚基(α、β和γ)。这些链的混合物可诱导从血浆蛋白中分离出来并用二磷酸腺苷(ADP)处理过的人类血小板发生聚集(结块)。当对纤维蛋白原的各个链进行测试时,γ链多聚体在与完整人纤维蛋白原相当的摩尔浓度下引起血小板聚集。β链无活性,α链的反应活性是γ链的1/4至1/5。针对γ链的单特异性抗体片段可抑制125I标记的纤维蛋白原与人类血小板受体的结合,并在存在纤维蛋白原或γ链多聚体的情况下阻断ADP诱导的血小板聚集。这些结果表明,人纤维蛋白原的γ链带有与血小板受体相互作用的主要位点。